CODX Research and Charts

CODX - Co-Diagnostics Inc Registered Shs (Healthcare: Diagnostics & Research)

Projected Earnings Date: 2024-08-12 (Delayed quote data 2026-02-05)

Last 2.35	Change ⇓ 0.00 (0.00%)	Volume 5,632
	Open 2.33	High 2.40	Low 2.30

8EMA (Daily) 2.55	40EMA (Daily) 5.10	50EMA (Daily) 5.76	STO (Daily) 6.924	MACD Hist (Daily) 0.156
8EMA (Weekly) 4.592	40EMA (Weekly) 10.06	50EMA (Weekly) 11.74	STO (Weekly) 1.414	MACD Hist (Weekly) -0.819


Company Profile
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV. The company's diagnostics systems enable very rapid, low-cost, sophisticated molecular testing for organisms and genetic diseases by greatly automating historically complex procedures in both the development and administration of tests.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.